The AJT report

American Journal of Transplantation

Volumn 14, Issue 5, 2014, Pages 985-986

  Pondrom, Sue ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSISTED CIRCULATION; BLEEDING; BLOODSTREAM INFECTION; EQUIPMENT FAILURE; FUNCTIONAL STATUS; HEALTH CARE POLICY; HEART FAILURE; HEART GRAFT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RESOURCE ALLOCATION;

EID: 84898959116     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12767     Document Type: Article

References (5)

1. Rose EA, Gelijns AC, Moskowit AJ, Heitjan DF, Sevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443.
2. Koval CE, Rakita R., AST Infectious Diseases Community of Practice. Ventricular assist device related infections and solid organ transplantation. Am J Transplant 2013; 13: 348-354.
3. Valika AA, Cotts W., A review of long-term mechanical circulatory support as destination therapy: Evolving paradigms for treatment of advanced heart failure. ISRN Transplantation 2013; Article ID 714373. Doi: 10.5402/2013/714373
4. Lund LH, Matthews J, Aaronson K., Patient selection for left ventricular assist devices. Eur J Heart Fail 2010; 12: 434-443.
5. Sabashnikov A, Patil NP, Mohite PM, Garcia Saez D, Zych B, Popov AF, et al. Influence of donor smoking on midterm outcomes after lung transplantation. Ann Thorac Surg. 2014; 97: 1015-1021.